Literature DB >> 6702750

Quality assurance of histopathologic diagnoses: a prospective audit of three thousand cases.

M E Whitehead, J E Fitzwater, S K Lindley, S B Kern, R C Ulirsch, W F Winecoff.   

Abstract

The purpose of this study was to examine a system of quality assurance in which microscopic slides from all surgical cases were subject to peer review before completion of the final pathology report. Three thousand surgical pathology cases were evaluated and the diagnoses entered on preliminary diagnosis sheets. Microscopic slides were reviewed and coded reviewer opinions entered on photostatic copies of preliminary diagnosis sheets. Reviewer comments were incorporated into the final pathology reports at the discretion of the responsible pathologist. Two hundred thirty-three (7.8%) cases were identified in which at least one reviewer disagreed with the preliminary diagnosis; in 67 of the 233 cases (2.2%) the final diagnosis was modified as a result of the review process. Changes in final diagnoses were judged to be significant in 29 (0.96%) cases. These results suggest that systematic review of surgical pathology diagnoses prior to preparation of final pathology reports may be a useful tool in assuring quality and consistency in diagnoses.

Mesh:

Year:  1984        PMID: 6702750     DOI: 10.1093/ajcp/81.4.487

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  Internal quality assurance activities of a surgical pathology department in an Australian teaching hospital.

Authors:  I M Zardawi; G Bennett; S Jain; M Brown
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

2.  Sarcomas in north west England: II. Incidence.

Authors:  A L Hartley; V Blair; M Harris; J M Birch; S S Banerjee; A J Freemont; J McClure; L J McWilliam
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

3.  Sarcomas in north west England: I. Histopathological peer review.

Authors:  M Harris; A L Hartley; V Blair; J M Birch; S S Banerjee; A J Freemont; J McClure; L J McWilliam
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.